Please find below the product information on the medicines mentioned in this e-learning:

Sources:  the latest* European Public Assesment Reports from the European Medicines Agency

* Whenever the product information is updated, the medicine’s EPAR is updated accordingly to reflect the latest version. For a new marketing authorisation or a major change to the authorisation terms, this process takes around two months following the adoption of an EMA scientific opinion, so there is a delay between adoption of opinion and publication or updating of the EPAR.